Resektabilität des Pankreaskarzinoms

详细信息    查看全文

• 作者：J. G. D'Haese ; Prof. Dr. J. Werner
• 关键词：Resectability criteria ; Tumor infiltration ; Radiology ; Surgery ; Borderline resectability
• 刊名：Der Radiologe
• 出版年：2016
• 出版时间：April 2016
• 年：2016
• 卷：56
• 期：4
• 页码：318-324
• 全文大小：5,232 KB
• 参考文献：1.Allema JH, Reinders ME, Van Gulik TM et al (1994) Portal vein resection in patients undergoing pancreatoduodenectomy for carcinoma of the pancreatic head. Br J Surg 81:1642–1646CrossRef PubMed
  2.Ammori JB, Colletti LM, Zalupski MM et al (2003) Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas. J Gastrointest Surg 7:766–772CrossRef PubMed
  3.Bilimoria KY, Bentrem DJ, Ko CY et al (2007) National failure to operate on early stage pancreatic cancer. Ann Surg 246:173–180CrossRef PubMed PubMedCentral
  4.Birkmeyer JD, Siewers AE, Finlayson EV et al (2002) Hospital volume and surgical mortality in the United States. N Engl J Med 346:1128–1137CrossRef PubMed
  5.Birkmeyer JD, Sun Y, Wong SL et al (2007) Hospital volume and late survival after cancer surgery. Ann Surg 245:777–783CrossRef PubMed PubMedCentral
  6.Burdelski CM, Reeh M, Bogoevski D et al (2011) Multivisceral resections in pancreatic cancer: identification of risk factors. World J Surg 35:2756–2763CrossRef PubMed
  7.Butturini G, Stocken DD, Wente MN et al (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg 143:75–83CrossRef PubMed
  8.Callery MP, Chang KJ, Fishman EK et al (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733CrossRef PubMed
  9.Chua TC, Saxena A (2010) Extended pancreaticoduodenectomy with vascular resection for pancreatic cancer: a systematic review. J Gastrointest Surg 14:1442–1452CrossRef PubMed
  10.Esposito I, Kleeff J, Bergmann F et al (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651–1660CrossRef PubMed
  11.Ferrone CR, Marchegiani G, Hong TS et al (2015) Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg 261:12–17CrossRef PubMed PubMedCentral
  12.Fuhrman GM, Leach SD, Staley CA et al (1996) Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223:154–162CrossRef PubMed PubMedCentral
  13.Gillen S, Schuster T, Meyer Zum Buschenfelde C et al (2010) Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med 7:e1000267CrossRef PubMed PubMedCentral
  14.Hackert T, Werner J, Weitz J et al (2010) Uncinate process first–a novel approach for pancreatic head resection. Langenbecks Arch Surg 395:1161–1164CrossRef PubMed
  15.Hartwig W, Hackert T, Hinz U et al (2011) Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg 254:311–319CrossRef PubMed
  16.Hartwig W, Hackert T, Hinz U et al (2009) Multivisceral resection for pancreatic malignancies: risk-analysis and long-term outcome. Ann Surg 250:81–87CrossRef PubMed
  17.Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362:1605–1617CrossRef PubMed
  18.Imamura M, Doi R, Imaizumi T et al (2004) A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 136:1003–1011CrossRef PubMed
  19.Katz MH, Pisters PW, Evans DB et al (2008) Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206:833–846; discussion 846–848
  20.Klauss M, Alt CD, Welzel T et al (2009) Multidetector CT evaluation of the course of nonresectable pancreatic carcinomas with neoadjuvant therapy. Pancreatology 9:621–630CrossRef PubMed
  21.Konstantinidis IT, Warshaw AL, Allen JN et al (2013) Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a „true“ R0 resection? Ann Surg 257:731–736CrossRef PubMed
  22.Mayo SC, Nathan H, Cameron JL et al (2012) Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent. Cancer 118:2674–2681CrossRef PubMed PubMedCentral
  23.Mollberg N, Rahbari NN, Koch M et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254:882–893CrossRef PubMed
  24.Morgan DE, Waggoner CN, Canon CL et al (2010) Resectability of pancreatic adenocarcinoma in patients with locally advanced disease downstaged by preoperative therapy: a challenge for MDCT. AJR. Am J Roentgenol 194:615–622CrossRef
  25.Neoptolemos JP, Stocken DD, Bassi C et al (2010) Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 304:1073–1081CrossRef PubMed
  26.Pessaux P, Rosso E, Panaro F et al (2009) Preliminary experience with the hanging maneuver for pancreaticoduodenectomy. Eur J Surg Oncol 35:1006–1010CrossRef PubMed
  27.Strobel O, Berens V, Hinz U et al (2012) Resection after neoadjuvant therapy for locally advanced, „unresectable“ pancreatic cancer. Surgery 152:S33–42CrossRef PubMed
  28.Varadhachary GR, Tamm EP, Abbruzzese JL et al (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046CrossRef PubMed
  29.Weitz J, Rahbari N, Koch M et al (2010) The „artery first“ approach for resection of pancreatic head cancer. J Am Coll Surg 210:e1–4CrossRef PubMed
  30.Werner J, Combs SE, Springfeld C et al (2013) Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol 10:323–333CrossRef PubMed
  31.Zhou Y, Zhang Z, Liu Y et al (2012) Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg 36:884–891CrossRef PubMed
  
• 作者单位：J. G. D’Haese (1)
  Prof. Dr. J. Werner (1)
  
  1. Klinik für Allgemeine, Viszeral-, Transplantations-, Gefäß- und Thoraxchirurgie, Klinikum der Universität München, Standort Großhadern, Marchioninistr. 15, 81377, München, Deutschland
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Imaging and Radiology
  General Practice and Family Medicine
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1432-2102

文摘

Background Pancreatic cancer is notoriously one of the most aggressive cancers and still has a poor prognosis. Surgical resection is the only chance for a curative therapy approach, with which at least a 5‑year survival can be achieved for 25 % of patients. Recent advances in surgical techniques have led to a change in the criteria for resectability.